FDA-acknowledged neurotoxin containing 300 units of ultra-purified (＞99.5%) Clostridium Botulinum Toxin Type A (CBFC26 strain). Clinically validated with 92% efficacy in reducing dynamic wrinkles within 72 hours. Maintains muscle relaxation for 4-6 months per treatment cycle. Manufactured under ISO 13485 certification.

PHARMACEUTICAL SPECIFICATIONS:
• Units/Vial: 300 IU ±5%
• Diluent: 0.9% NaCl (7.5ml)
• Storage: 2-8°C (lyophilized)
• Manufacturer: Hugel Pharma (KFDA Approved)

CLINICAL PROTOCOL:
1. Reconstitute with 7.5ml sterile saline
2. Administer intramuscularly via 30G needle
3. Max dosage: 400U/90 days (FDA)
4. Avoid manipulation ×24hrs post-treatment
⚠ Contraindicated in neuromuscular disorders

MEDICAL DISCLAIMER: Results may vary 15-20% based on individual muscle physiology. Prescription-only medication requiring administration by licensed practitioners. Not recommended for patients with myasthenia gravis or peripheral motor neuropathies. Adverse effects including ptosis (2-5% incidence) typically resolve spontaneously.